Founded in 2021, Dr Angela Genge brings her 25+ years of experience as an internationally recognized opinion leader in the spaces of drug design and rare disease to Genge Partners.
Combining the efficiencies of a private practice setting and the expertise of an academic clinical trial setting, Genge Partners will provide access to patient populations and operational expertise to you and your partners.
Over the course of her career, Dr Genge has championed upcoming and new therapies to international audiences including South Africa, Colombia, the Gulf Region, North America and Europe.